These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19204667)

  • 1. The worst of times, the best of times.
    Nat Biotechnol; 2009 Feb; 27(2):101. PubMed ID: 19204667
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotechnology. French drug industry initiative.
    Anderson C
    Nature; 1991 Oct; 353(6344):487. PubMed ID: 1922346
    [No Abstract]   [Full Text] [Related]  

  • 3. Best-selling human medicines 2002-2004.
    Maggon K
    Drug Discov Today; 2005 Jun; 10(11):739-42. PubMed ID: 15922927
    [No Abstract]   [Full Text] [Related]  

  • 4. When times get tough.
    Jong S
    Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
    [No Abstract]   [Full Text] [Related]  

  • 5. BIO 2006 Annual International Convention. The current state of the global biotechnology industry.
    Zarkowska T
    IDrugs; 2006 Jun; 9(6):381-2. PubMed ID: 16752301
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotechnology at Yale.
    Shiao S
    Yale J Biol Med; 2001; 74(3):197-9. PubMed ID: 11501716
    [No Abstract]   [Full Text] [Related]  

  • 7. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology company's shares dive 67% after drug failure.
    Dobson R
    BMJ; 2000 Oct; 321(7268):1039. PubMed ID: 11053161
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 10. Celera buys Axys.
    Morrison C
    Nat Biotechnol; 2001 Aug; 19(8):703-5. PubMed ID: 11479548
    [No Abstract]   [Full Text] [Related]  

  • 11. Is there balm in Gilead?
    Jacobs T
    Nat Biotechnol; 2006 Dec; 24(12):1478. PubMed ID: 17160040
    [No Abstract]   [Full Text] [Related]  

  • 12. Swooping for biotech.
    Wadman M
    Nature; 2005 Sep; 437(7058):475. PubMed ID: 16177760
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech at the beauty counter.
    Nasto B
    Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquisition signals shift from US market.
    Mitchell P
    Nat Biotechnol; 2005 Jun; 23(6):635. PubMed ID: 15940218
    [No Abstract]   [Full Text] [Related]  

  • 15. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 16. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 17. The policy outlook from the Hill.
    Vastag B
    Nat Biotechnol; 2007 Jan; 25(1):13-6. PubMed ID: 17211381
    [No Abstract]   [Full Text] [Related]  

  • 18. Investing in oncology biotech stocks.
    Feuerstein A
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
    [No Abstract]   [Full Text] [Related]  

  • 19. Teva to acquire Chinese biogenerics manufacturer.
    Katsnelson A
    Nat Biotechnol; 2005 Jul; 23(7):765. PubMed ID: 16003343
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech slumps in Q1.
    Lawrence S
    Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.